A Match Made at RESI: Part II

By Rory McCann, Marketing Manager & Conference Producer, LSN

Antoine Prestat and Michele Marzola met at Digital RESI March and spent the past several months building up a strategic partnership that will help launch French biotech, PEP-Therapy into clinical trials this summer.

In Part II of our two-part interview about Michele and Antoine’s strategic partnership, we discuss how PEP-Therapy stood out at RESI, and how Antoine worked with investors for a strong Series A raise.

Check out Part I of our interview and if you’re looking to get in front of qualified investors at Digital RESI June, there’s still time to sign up!

Join These Investor Panelists at Digital RESI June

By Joey Wong, Investor Research Analyst, LSN

Digital Redefining Early Stage Investment (RESI) Conference, June 8-10, takes place in just a few weeks! The Life Science Nation (LSN) investor research team has been busy organizing six exciting panels focusing on different investor groups, from big pharma, corporate venture capital, to family offices and angel investors, etc. During these panels, active life science investors will share their insight and provide tactical advice on outreach, positioning, and building the right relationships to move products forward. The goal is to facilitate constructive conversations between investors and fundraising CEOs, and provide insights on how companies can raise capital and acquire partnerships effectively.

Another exciting part of the upcoming conference is the Innovator’s Pitch Challenge, where investors and industry experts are invited to participate in the live Q&A sessions to give feedback and ask questions to the pitching companies.

If you are interested in meeting these investor panelists and pitch judges, register here for Digital RESI June! Partnering is open, but there is still time to sign up!

For those who have already registered, we highly recommend you to join the panels that are relevant to your company; you can RSVP for any panels in the partnering system to block off your meeting schedule.

Here are some of the investors who will be joining our panels and pitch sessions at Digital RESI June:

Hamzeh Abdul-Hadi
Principal
Hikma Ventures
Brent Ahrens
General Partner
Canaan Partners
Faz Bashi
Member of BOD
Life Science Angels
Attila Bérces
Advisor
FastVentures
Brian Bronk
Head of External Innovation, Rare Diseases
Sanofi
Hannah Chang
Managing Director
Wu Capital
Elizabeth Cho-Fertikh
Co-Founder & Managing Director
Meda Angels
Chris Church
Associate Director, Search & Evaluation, CVRM
AstraZeneca
Juan Cueva
Senior Associate
Action Potential Venture Capital
Geoff Dacosta
Director, Business Development and Licensing
Medtronic
Ben Evans
Managing Director
InHealth Ventures
Naomi Fried
Managing Director & Co-Founder
Ambit Health Ventures
Robert Garber
Partner
7wire Ventures
Miles Gerson
Partner
Takeda Ventures
Sam Goldberger
Co-Founder & Managing Partner
Ambit Health Ventures
Sherry Grisewood
Senior Investment Officer
FoxHill Asset Management
Bryan Grulke
Partner
Volcano Capital
Eric Heinz
Director, Business Development (M&A)
Smith & Nephew
Merom Klein
Entrepreneur Mentor
Keiretsu Forum
Marc Martin-Casas
Seed Investments & Development
Illumina Accelerator
Andy Merken
Partner, Corporate and Securities Co-Chair, Life Sciences
Burns & Levinson
Brian Meshkin
Managing Partner, Profound Ventures Partner, Cancer Fund
Profound Ventures
Petra Meyer
Managing Director – HealthCare Sector Group Lead
Golden Seeds
Junaid Mian
Managing Partner & Longevity Lead
SP8CEVC
Nicholas Mourlas
Senior Director, New Ventures
Johnson & Johnson Innovation
Ashley Ng
Director
McKesson Ventures
John Parker
Founder & Managing Director
Springhood Ventures
Richard Proscia
Senior Associate
Providence Ventures
Meghana Rao
Senior Manager, New Venture Transactions
Johnson & Johnson Innovation
Nadav Shimoni
Head, Digital Health
Arkin Holdings Ltd
Yaniv Sneor
Founding Member
Mid Atlantic Bio Angels
Jill Sorensen
Chief Operating Officer
Medical Technology Enterprise Consortium (MTEC)
Eran Steinberg

 

Imaging Arts

Ben Sun
Investor/member
Sand Hill Angels
Anna Turetsky
Principal, Venture Investments
The Mark Foundation for Cancer Research (MFCR)
Thomas Vogelsong
Investor/Life Science Advisor
KYTO Technology and Life Science
 
Scott Weiner
Partner
Amzak Health
Tim Xiao
Principal
Delos Capital
John Yianni
Managing Partner
Earlybird
 

Introducing RESI AI Panels

By Caitlin Dolegowski, Marketing Specialist, LSN

Caiti

Life Science Nation has released panel topics for its upcoming digital partnering conference: RESI AI, September 16-17. RESI AI panels host active investors who are joined by founders of portfolio companies to discuss funding, the early-stage landscape for AI companies in healthcare, and what makes a successful strategic partnership. Register by July 23 to save on super early bird rates.

There are many exciting advancements in this dynamic sector of life sciences, and we hope you’ll join us in highlighting the latest innovations, as well as take advantage of the powerful partnering system that has made RESI events a mainstay in early-stage fundraising.

If you’d like to be considered to join a RESI AI panel, please apply here.

The RESI AI panels will focus on the following topics:

Healthcare Communications

Bridging the Gaps between Patient and Provider

Communication between patients and providers is essential to health systems globally. AI-enabled technology addressing these needs and creating innovative solutions help patients better access and comprehend their options and care. Hear from early-stage founders connecting the healthcare system one relationship at a time.

Accelerated Pharmaceutical Development

Advancing and Optimizing Clinical Processes

AI is a necessary component of many aspects of the development of pharmaceuticals. However, the COVID-19 global pandemic has highlighted the need for rapid and reliable pharmaceutical advancement. Learn how researchers can utilize AI to optimize performance and save lives.

Reproductive Wellness

Highlighting Innovation and Broad Applications

Comprehensive reproductive care has a global impact on health and society. AI-assisted advancement in this field is critical to provide access to patients regardless of location, medical history, and socioeconomic status. Hear from leaders how their technology is creating equity in quality and excellence in care.

Diagnostic Wearables

Connecting Patients to Their Health

Wearable sensors are a fast-growing area of medical device and diagnostic technology. The function and accuracy of these devices are critical to patient care and communication. AI is a powerful tool equipping these to provide accurate results up to the moment and enabling users to make well-informed decisions on their health.

Healthcare Systems and Infrastructure

Creating Synergy for Efficient Patient Care

Optimized healthcare systems and digital infrastructure are paramount to the patient experience. From electronic health records to portal access and communications, AI-enabled medical centers are better equipped to help patients in the digital age. When it comes to healthcare, small synergistic changes create a big impact on the patient experience and contribute to better systems globally.

Precision Medicine

Fitting the AI Piece of the Puzzle

The AI impact on precision medicine is essential in targeting and treating genetic disorders, rare diseases, oncology, and more. It’s important that entrepreneurs learn how to navigate pitfalls such as market saturation, regulatory risk and guidelines, as well as how to better define patient populations, challenges and tackle manufacturing and commercialization.

A Match Made at RESI: Part I

By Rory McCann, Marketing Manager & Conference Producer, LSN

Michele Marzola is a prolific investor and entrepreneur in healthcare with a career that spans decades. He knows exceptional technology when he sees it and a powerful team when he meets them, so when he met Antoine Prestat, founder of PEP-Therapy at RESI March 2020, he knew he’d found something special.

In Part I of our two-part interview about Michele’s investment in PEP-Therapy, we discuss his process when sourcing assets, due diligence, digital partnering, and his best advice to fundraising entrepreneurs.

There’s still time to sign up for Digital RESI June! Register today to start booking meetings with over 350 investors.  

Introducing RESI AI Panels

By Elizabeth Murphy, Manager of Business Development, LSN

It is with great pleasure that we announce the upcoming panel discussions for the RESI AI digital partnering conference, September 16-17. Register by July 23 to save on super early bird rates and save an additional $100 with code: MANDATE100.

Apply here for the chance to join one of the following panel discussions:

Healthcare Communications

Bridging the Gaps between Patient and Provider

Communication between patients and providers is essential to health systems globally. AI-enabled technology addressing these needs and creating innovative solutions help patients better access and comprehend their options and care. Hear from early-stage founders connecting the healthcare system one relationship at a time.

Accelerated Pharmaceutical Development

Advancing and Optimizing Clinical Processes

AI is a necessary component of many aspects of the development of pharmaceuticals. However, the COVID-19 global pandemic has highlighted the need for rapid and reliable pharmaceutical advancement. Learn how researchers can utilize AI to optimize performance and save lives.

Reproductive Wellness

Highlighting Innovation and Broad Applications

Comprehensive reproductive care has a global impact on health and society. AI-assisted advancement in this field is critical to provide access to patients regardless of location, medical history, and socioeconomic status. Hear from leaders how their technology is creating equity in quality and excellence in care.

Diagnostic Wearables

Connecting Patients to Their Health

Wearable sensors are a fast-growing area of medical device and diagnostic technology. The function and accuracy of these devices are critical to patient care and communication. AI is a powerful tool equipping these to provide accurate results up to the moment and enabling users to make well-informed decisions on their health.

Healthcare Systems and Infrastructure

Creating Synergy for Efficient Patient Care

Optimized healthcare systems and digital infrastructure are paramount to the patient experience. From electronic health records to portal access and communications, AI-enabled medical centers are better equipped to help patients in the digital age. When it comes to healthcare, small synergistic changes create a big impact on the patient experience and contribute to better systems globally.

Precision Medicine

Fitting the AI Piece of the Puzzle

The AI impact on precision medicine is essential in targeting and treating genetic disorders, rare diseases, oncology, and more. It’s important that entrepreneurs learn how to navigate pitfalls such as market saturation, regulatory risk and guidelines, as well as how to better define patient populations, and tackle manufacturing and commercialization challenges.

Don’t Miss Out on the Innovator’s Pitch Challenge (IPC) – Applications Due Tomorrow!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Tomorrow is the last day to apply for the Innovator’s Pitch Challenge (IPC) at Digital Redefining Early Stage Investments (RESI), June 8-10. While IPC is a relatively new addition to our conferences, it has received overwhelmingly positive feedback from participating companies and investor judges alike. It is a great way for companies to boost their exposure among the life sciences community, especially to investors and strategic partners. For investors, the IPC serves as a fun and informative way to virtually engage with innovative companies. It is not a surprise that post-IPC follow-ups often lead to productive discussions for potential investment or strategic partnership.

We have received a record-breaking number of applications for this event and are quickly filling up to capacity. If you are interested in a unique, unparalleled opportunity to showcase your technology, please make sure to apply by tomorrow, Friday, May 14!

Digital RESI June Partnering Opens Monday

By Karen Deyo, Director of Investor Research, Israel BD, LSN

With the next Redefining Early Stage Investments (RESI) conference just around the corner, we launch the partnering platform Monday, May 17. RESI partnering offers companies a unique opportunity to send targeted meeting requests to investors who are a fit for them based on many customizable variables, including product fit and stage of development. This targeted approach leads to a much higher number of quality meetings, along with a much higher likelihood of getting follow-up meetings after RESI.

At Life Science Nation (LSN), we are dedicated to helping companies optimize their experience at our events. We will be offering multiple webinars to attendees, providing tips and advice on how to best navigate the platform and book more meetings. We also offer the below resources, where we have previously written about ways companies can maximize the results to their efforts. Feel free to reach out to the LSN staff at any time with questions – we are happy to help!

Access past articles on best partnering practices:

Make sure to sign up before Monday to get access to the platform as it launches!